Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

Because aircraft personnel are routinely exposed to galactic cosmic and ultraviolet radiation, they face an elevated risk for skin cancer.

The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...

Regeneron Pharmaceuticals has won expanded European approval of its blockbuster cancer drug Libtayo for certain patients with skin cancer. Regeneron on Wednesday said the European Commission's nod ...

Skin cancer impacts millions of Americans annually, but your chances of getting skin cancer and when it is diagnosed depend ...

Researchers have uncovered that SerpinB3, typically linked to severe cancers, is also a key player in natural wound healing.

Stage 2 vaginal cancer involves spread beyond the vaginal wall but not to the pelvic sidewall, with symptoms like abnormal ...

A new large-scale study suggests that a simple, over-the-counter vitamin could play a major role in preventing skin cancer.

The panel is able to independently predict metastasis, local recurrence, and overall survival in patients with cutaneous squamous cell carcinoma, researchers reported.

Regeneron gains EC approval to expand Libtayo's use in high-risk CSCC. The FDA approves Eylea HD the treatment of patients with macular edema following retinal vein occlusion.